Jingnan Shen

1.7k total citations
31 papers, 1.2k citations indexed

About

Jingnan Shen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jingnan Shen has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jingnan Shen's work include MicroRNA in disease regulation (8 papers), Sarcoma Diagnosis and Treatment (7 papers) and Cancer-related molecular mechanisms research (7 papers). Jingnan Shen is often cited by papers focused on MicroRNA in disease regulation (8 papers), Sarcoma Diagnosis and Treatment (7 papers) and Cancer-related molecular mechanisms research (7 papers). Jingnan Shen collaborates with scholars based in China, United States and Canada. Jingnan Shen's co-authors include Xianbiao Xie, Junqiang Yin, Changye Zou, Qinglian Tang, Jinchang Lu, Gang Huang, Tingsheng Peng, Xuedi Wang, Yongqian Wang and Tiebang Kang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jingnan Shen

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingnan Shen China 17 939 663 206 160 76 31 1.2k
Changye Zou China 18 901 1.0× 523 0.8× 189 0.9× 164 1.0× 71 0.9× 31 1.2k
Qiao‐Li Lv China 21 767 0.8× 552 0.8× 124 0.6× 95 0.6× 93 1.2× 64 1.1k
Sima Orouei Iran 16 571 0.6× 379 0.6× 167 0.8× 89 0.6× 72 0.9× 19 848
Hongyan Jin China 20 879 0.9× 557 0.8× 219 1.1× 65 0.4× 111 1.5× 32 1.3k
Yi Xiao China 19 668 0.7× 344 0.5× 316 1.5× 135 0.8× 79 1.0× 71 1.1k
Shengni Hua China 16 829 0.9× 587 0.9× 253 1.2× 122 0.8× 76 1.0× 22 1.1k
Nermin Kahraman United States 16 686 0.7× 373 0.6× 151 0.7× 71 0.4× 90 1.2× 32 913
Yun‐Xin Lu China 17 856 0.9× 640 1.0× 235 1.1× 183 1.1× 92 1.2× 40 1.2k
Min Kyung Ju South Korea 12 691 0.7× 469 0.7× 365 1.8× 136 0.8× 100 1.3× 16 1.1k

Countries citing papers authored by Jingnan Shen

Since Specialization
Citations

This map shows the geographic impact of Jingnan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingnan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingnan Shen more than expected).

Fields of papers citing papers by Jingnan Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingnan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingnan Shen. The network helps show where Jingnan Shen may publish in the future.

Co-authorship network of co-authors of Jingnan Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Jingnan Shen. A scholar is included among the top collaborators of Jingnan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingnan Shen. Jingnan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Jingnan, et al.. (2025). Automatically Inverse Design of FSSs by Conditional Variational Autoencoder and Equivalent Circuit Models With Large Language Models. IEEE Transactions on Antennas and Propagation. 73(11). 8922–8932.
2.
Ma, Zeqiang, et al.. (2024). Overexpression of ALDOC Promotes Porcine Intramuscular and Intermuscular Fat Deposition by Activating the AKT-mTORC1 Signaling Pathway. Journal of Agricultural and Food Chemistry. 72(43). 23893–23907. 3 indexed citations
3.
Xie, Lu, Jie Xu, Xin Sun, et al.. (2024). ARTEMIS-002: Phase 2 study of HS-20093 in patients with relapsed or refractory osteosarcoma.. Journal of Clinical Oncology. 42(16_suppl). 11507–11507. 10 indexed citations
4.
Zou, Yutong, Siyao Guo, Dongming Lv, et al.. (2024). Targeting NAT10 inhibits osteosarcoma progression via ATF4/ASNS-mediated asparagine biosynthesis. Cell Reports Medicine. 5(9). 101728–101728. 6 indexed citations
5.
Shen, Jingnan, et al.. (2023). A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma. Bioengineering. 10(10). 1121–1121. 6 indexed citations
6.
Zhao, Zhiqiang, Tiao Lin, Gang Huang, et al.. (2023). Preoperative denosumab treatment in patients with giant cell bone tumors in limbs: A retrospective study using propensity score matching. Cancer Medicine. 12(11). 12041–12049. 4 indexed citations
7.
Li, Hongbo, Gang Huang, Jian Tu, et al.. (2022). METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma. EBioMedicine. 82. 104142–104142. 57 indexed citations
8.
Liao, Dan, Li Zhong, Junqiang Yin, et al.. (2020). Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. Nature Cell Biology. 22(7). 868–881. 47 indexed citations
9.
Zhang, Jiajun, Weihai Liu, Changye Zou, et al.. (2020). Targeting Super-Enhancer–Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor. Clinical Cancer Research. 26(11). 2681–2692. 44 indexed citations
10.
Liao, Dan, Li Zhong, Junqiang Yin, et al.. (2020). Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. Nature Cell Biology. 22(7). 907–907. 1 indexed citations
11.
Shen, Jingnan, et al.. (2019). Grape seed procyanidin B2 promotes the autophagy and apoptosis in colorectal cancer cells via regulating PI3K/Akt signaling pathway. SHILAP Revista de lepidopterología. 2 indexed citations
12.
Tang, Qinglian, Jinchang Lu, Changye Zou, et al.. (2018). CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis. Oncogene. 37(27). 3617–3630. 26 indexed citations
13.
14.
Jiang, Nian, Xuedi Wang, Xianbiao Xie, et al.. (2017). lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition. Cancer Letters. 405. 46–55. 178 indexed citations
15.
Lu, Jinchang, Guohui Song, Qinglian Tang, et al.. (2015). IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling. Journal of Clinical Investigation. 125(5). 1839–1856. 98 indexed citations
16.
Song, Guohui, Changye Zou, Qinglian Tang, et al.. (2014). Dihydromyricetin Activates AMP-Activated Protein Kinase and P38MAPK Exerting Antitumor Potential in Osteosarcoma. Cancer Prevention Research. 7(9). 927–938. 47 indexed citations
17.
Hu, Qiang, Qiong Jiang, Xiaodong Jin, et al.. (2013). Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model. Biomaterials. 34(9). 2265–2276. 95 indexed citations
18.
Zhao, Zhiqiang, Changye Zou, Qinglian Tang, et al.. (2013). Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway. Cancer Letters. 342(1). 150–158. 94 indexed citations
19.
Yin, Junqiang, Li‐Li Wen, Liang‐Cai Wu, et al.. (2012). The glycogen synthase kinase-3β/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells. Toxicology Letters. 218(2). 129–136. 35 indexed citations
20.
Jin, Song, Jingnan Shen, Jin Wang, Gang Huang, & Jia‐Guo Zhou. (2007). Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells. Cancer Biology & Therapy. 6(2). 261–268. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026